About RSNA

2008 Report of the Secretary-Treasurer

Gary J. Becker, MD Secretary-Treasurer

I am pleased to report that the Society accepted 4,069 new members during the year 2008.

We annually promote membership in our Society to new radiology residents and medical students. Through this year's promotional efforts 2,983 radiology residents and medical students joined the Society (1,413 new Members-in-training, 1,124 new Corresponding Members-in-training, 92 Fellows, and 354 Medical Students). We are pleased to see the radiologists-in-training and medical students take advantage of the great opportunities offered to them by joining the Society. Members-in-training and medical students do not pay dues, have free access to RSNA online journals and InteractED, are allowed free admission to the RSNA Scientific Assembly and Annual Meeting, and may subscribe to the printed copy of Radiology and RadioGraphics, at a highly subsidized rate.

RSNA Record of Membership
	Active	Assoc	Med Stu	MIT	Cor.-MIT	Emeritus	Retired	Honorary	Corresp	RA/RT	Totals
2007	19,440	811	1,082	8,014	3,183	4	4,292	64	4,385	24	41,299
2008	19,604	909	823	8,260	3,609	0	4,451	66	4,621	39	42,382
Net Difference	164	98	-259	246	426	0	159	2	236	15	1,083

I regret to report the passing of the colleagues named below as of October 31, 2008. The Society mourns their deaths, comforted by the knowledge of their many devoted services to the health and well-being of the communities in which they practiced medicine.

Deceased RSNA Members from 11/1/07 - 10/31/08
Fidel A. Aguirre, MD, Miami, FL (R58)
Nathan Arenson, MD, Gulf Breeze, FL (R50)
Marc A. Asselin, MD, Brossard, QC Canada (R82)
Michael P. Barry, MD, Westmount, QC Canada (R61)
Alexander S. Belman, MD, Macungie, PA (R76)
Arthur F. Bishop, MD, Peoria, IL (M81)
Paul D. Boschult, MD, Omaha, NE (R73)
Stephen W. Brown, MD, Augusta, GA (R47)
Jack A. Brucher, MD, Savannah, GA (R69)
Joseph D. Calhoun, MD, Little Rock, AR (R51)
Donald M. Callahan, MD, Harrisonburg, VA (R67)
Kathran M. Chan, MD, Dayton, OH (M84)
Sridhar R. Charagundla, MD, PhD, Philadelphia, PA (G00)
Sergio A. Chavez Lopez, MD, Zacapu, Michoacan Mexico (M99)
Herbert B. Copeland, MD, Naples, FL (R53)
Leonard Davis, MD, Sherman Oaks, CA (R61)
Larry E. De Volld, MD, Canyon Lake, TX (M79)
Samuel J. Dwyer III, PhD, Charlottesville, VA (A94)
William D. Eggleston, MD, Toledo, OH (R76)
Samuel B. Feinberg, MD, Minneapolis, MN (R56)
Alvin W. Finestone, MD, Clifton Forge, VA (R60)
Albert P. Fischer, Jr, MD, Sun City Center, FL (R89)
Henry J. Fox, MD, Fairfield, CT (R58)
Keith W. Gallehugh, MD, Overland Park, KS (R69)
Eva L. Gilbertson, MD, Seattle, WA (R48)
Jerome J. Gleich, MD, Fairfield, IA (M78)
Melvin A. Golden, MD, Lubbock, TX (M74)
James R. Guyton, Jr, MD, Lenoir City, TN (R73)
Robert A. Harris, DO, Dublin, OH (M84)
Bruce H. Hasegawa, PhD, San Francisco, CA (A89)
Ernest M. Henken, MD, East Hartford, CT (R58)
Julius Heydemann, MD, Chiago, IL (R49)
Martin Hochhauser, MD, Palm City, FL (R64)
Thure M. Holm, MD, Lund, Sweden (H82)
Erwin P. Huang, MD, Toronto, ON Canada (R71)
Sophia C. Johnson, MD, Miami, FL (T05)
Richard M. Kafka, MD, Alexandria, VA (R53)
Hitoshi Katayama, MD, Kokubunji City, Tokyo, Japan (H84)
Thomas Keely, Jr, MD, Tucson, AZ (R56)
Max C. King, MD, Decatur, GA (R74)
Vernon V. Kirby, Jr, MD, Forestburg, TX (R64)
Nelson E. Klamm, MD, Palm Harbor, FL (R57)
Harvey A. Koolpe, MD, Elkins Park, PA (M91)
Leonard O. Langer, Jr, MD, Minneapolis, MN (R69)
Charles D. Le Neave, MD, Mayfield, KY (R68)
Steven A. Leibel, MD, Stanford, CA (M99)
Wolfe Light, MD, Montreal, QC Canada (R52)
Robert L. Lindsay, MD, DDS, Knoxville, TN (M92)
Paul Loewe, MD, Mexico, DF Mexico (R54)
John H. Lohnes, MD, Cedar Rapids, IA (R65)
Steven C. Malchow, MD, Scottsdale, AZ (M94)
Frank H. Marek, MD, Lake Charles, LA (R48)
John G. McAfee, MD, Chevy Chase, MD (M56)
M. Donald Merrill, MD, Saint George, UT (R63)
Abdul-Halim Mheir, MD, Outremont, QC Canada (R72)
J. Thomas Miller, Jr, MD, Markle, IN (R76)
Warren A. Nafis, MD, Glendora, CA (R66)
Elise M. Neeld, MD, Nevis, MN (R72)
Robert E. Paul, Jr, MD, Northborough, MA (R66)
Henry P. Pendergrass, MD, Gladwyne, PA (R57)
Harvey Picker, Camden, ME (H97)
Mario P. Pliego, MD, Bloomington, MN (R81)
James A. Pollock, MD, Sacramento, CA (R79)
Walter E. Powers, MD, Des Plaines, IL (R69)
Ernest H. Price, MD, San Diego, CA (R55)
John E. Prominski, MD, Arlington, VA (R64)
Robert S. Richards, MD, Marblehead, MA (R64)
Charles H. Robinson, MD, El Paso, TX (R71)
David L. Robinson, MD, Tyler, TX (R79)
Wayne D. Ross, MD, Chestnut Hill, MA (R59)
Joel F. Sammet, MD, Highland Park, IL (R48)
James A. Schelble, MD, Milwaukee, WI (R57)
Ralph Schlaeger, MD, New York, NY (R56)
Alvin D. Sears, MD, Dallas, TX (R62)
William R. Seibold, Jr, MD, Texarkana, TX (R63)
Janina Sekowski, MD, Rego Park, NY (R83)
Avishai W. Shapiro, MD, Lexington, MA (M91)
Eugene B. Sharpe, MD, Asheville, NC (R70)
Jason Sheehan, MBBCh, Toledo, OH (T06)
Lester D. Shook, MD, Fargo, ND (R52)
Stanley W. Siegler, MD, Sea Girt, NJ (R64)
John D. Stevenson, MD, West Vancouver, BC Canada (R56)
Karen J. Stuck, MD, Northville, MI (M78)
Eldred B. Teague, MD, Birmingham, AL (R49)
Weawdao Techawattanakul, MD, Chiengrai, Thailand (C04)
Mark A. Vasa, MD, Brockton, MA (M02)
F. Robert Walch, MD, Sarasota, FL (R70)
Sheldon Waldman, MD, Pompano Beach, FL (R80)
Orliss Wildermuth, MD, Seattle, WA (R55)
Richard D. Wolfe, MD, Fairfield, CA (R79)
Brian S. Worthington, MD, Derbyshire, United Kingdom (H89)

Financial Statements

The financial statements for the fiscal year ended June 30, 2008, reflect positive earnings for the Society.

Although it has been a challenging year for the investment markets, the Society continues to experience financial growth. The return on investments is especially important for the Society's Research and Education Foundation, as its ability to fund grants is directly impacted by investments earnings. The continued financial growth of the Society has helped increase its reserves, which helps protect the RSNA from any significant economic downturns and provides available funds for future programs and initiatives.

Wolf & Company LLP completed its annual audit of the Society's financial statements issuing an unqualified opinion, indicating that Wolf & Company LLP found no material differences to the financial information presented in the Society's year-end financial statements. In addition Wolf & Company LLP indicated to the Audit Committee that it did not find any material weaknesses in the Society's internal accounting procedures.

The following Balance Sheet and Statement of Activities have been condensed from the year-end audit report prepared by Wolf & Company LLP, as of June 30, 2008. The detailed audited report is kept on file at the RSNA's headquarters: Radiological Society of North America, 820 Jorie Boulevard, Oak Brook, IL 60523. It is available for review there by members of the RSNA.

Gary J. Becker, MD
Secretary-Treasurer

Statement of Financial Position June 30, 2008
ASSETS
Cash and Short-Term Investments	$5,509,214
Receivables and Other Current Assets	4,058,301
Long-Term Investments	73,433,161
Property, Furniture and Equipment	22,687,258
Total Assets	$105,687,934
Liabilities and Net Assets
Accounts Payable and Short-Term Debt	$2,036,473
Deferred Revenue	11,561,887
Long-Term Debt and Other Long-Term Liabilities	8,701,205
Net Assets:
Unrestricted:
Undesignated	36,546,298
Designated-Research and Education Foundation	27,889,857
Restricted:
Temporarily restricted	2,650,238
Permanently restricted	16,301,976
Total net assets	83,388,369
Total Liabilities and Net Assets	$105,687,934

Statement of Activities Year ending June 30, 2008
REVENUE
Membership Services	$4,632,364
Publications and Educational Materials	11,224,030
Annual Scientific Assembly	25,119,082
Investment Earnings	4,454,680
Contributions	4,129,383
Total Revenue	$49,559,539
EXPENSES
Membership Services	$4,784,148
Publications and Educational Materials	16,847,914
Annual Scientific Assembly	14,623,225
Research and Education Foundation	3,178,255
Depreciation	908,480
Total Expenses	$40,342,022
Increase in net assets before unrealized gain (loss) on investments	$9,217,517
Unrealized gain (loss) on valuation of investments and interest rate swap	(6,503,793)
Increase in Net Assets	$2,713,724
Net Assets at beginning of year	80,674,645
Net Assets at end of year	$83,388,369